Assessment
durvalumab
First-line treatment of advanced or unresectable hepatocellular carcinoma (HCC)
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relationsAssessment
First-line treatment of advanced or unresectable hepatocellular carcinoma (HCC)
Connected evidence
2 relations